Send a Tweet
Most Popular Choices
Poll Analyses
Share on Facebook 7 Share on Twitter 1 Printer Friendly Page More Sharing
Sci Tech    H4'ed 7/25/17

Companies Rush to Develop 'Utterly Transformative' Gene Therapies -

Author 40790
Follow Me on Twitter     Message Susan Lee Schwartz
Become a Fan
  (22 fans)

File:Thecure-logo.svg - Wikimedia Commons1024 ├-- 493 - 54k - png
File:Thecure-logo.svg - Wikimedia Commons1024 ├-- 493 - 54k - png
(Image by commons.wikimedia.org)
  Details   DMCA

'Gene therapy for cancer is becoming a reality but works best for blood cancers like leukemia and not yet in more common ones like lung cancer. The approval of gene therapy for leukemia, expected in the next few months, will open the door to a radically new class of cancer treatments.Companies and universities are racing to develop these new therapies, which re-engineer and turbocharge millions of a patient’s own immune cells, turning them into cancer killers that researchers call a “living drug.” One of the big goals now is to get them to work for many other cancers, including those of the breast, prostate, ovary, lung and pancreas.But it will take time to find that out, he said, at least five years'

Read the rest of the story HERE:

At www.nytimes.com

 

Rate It | View Ratings

Susan Lee Schwartz Social Media Pages: Facebook Page       Twitter Page       Linked In Page       Instagram Page

I began teaching in 1963,; Ba and BS in Education -Brooklyn College. I have the equivalent of 2 additional Master's, mainly in Literacy Studies and Graphic Design. I was the only seventh grade teacher of English from 1990 -1999 at East Side (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Follow Me on Twitter     Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: